Reason: cGMP deviations
Distributed: Product was distributed USA nationwide.Reason: cGMP deviations
Distributed: Product was distributed USA nationwide.Reason: cGMP deviations
Distributed: Product was distributed USA nationwide.Reason: cGMP deviations
Distributed: Product was distributed USA nationwide.Reason: cGMP deviations
Distributed: Product was distributed USA nationwide.Reason: cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
Distributed: USA NationwideReason: Packaging defect: blister packaging inadequately sealed.
Distributed: Nationwide in the U.S.Reason: Labeling: Label Mix-up: Unit Dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg were found to contain blister packages labeled as and containing Dronabinol Capsules, USP, 2.5 mg.
Distributed: Nationwide in the USAReason: Failed Impurities/Degradation Specifications
Distributed: Nationwide within the United StatesReason: Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)
Distributed: LA, PA and OH.